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Abstract
Background: Bovine tuberculosis (bTB) remains a significant problem in some parts of Spain
largely because of contacts between cattle and wildlife reservoirs in extensive grazing systems.
European Wild boar (Sus scrofa) is one of the species involved in the transmission of the disease to
other species. Fast and simple detection methods would be critical for assessing infection
prevalence, study the mechanisms of pathogen transmission and monitoring the effects of TB
control measures.
Results:  An enzyme-linked immunosorbent assay (ELISA) to detect antibodies against
Mycobacterium bovis in wild boar serum was developed and validated on 185 sera from TB positive
and negative wild boar. Based on antigen inoculation of captive animals as well as tuberculosis
compatible lesions, culture results and molecular analysis of hunted individuals, animals were
allocated into two groups: tuberculosis positive group and tuberculosis negative group. After
optimization of the positive to negative ratio using different combinations of serum dilutions and
conjugate concentrations, the test yielded a sensitivity of 72.60% and a specificity of 96.43% for the
best cut-off.
Conclusion: Although some negative group animals showed an ELISA positive reaction (< 3%),
this assay showed a high potential for accurate diagnosis of TB in wild boar, as its large dynamic
range supported a good discriminatory power and a satisfactory balance between sensitivity and
specificity.
Background
Bovine tuberculosis, caused by Mycobacterium bovis and
other closely related mycobacteria of the Mycobacterium
tuberculosis complex, is endemic in many countries. These
mycobacteria can infect a wide range of domestic and wild
animals [1-3]. Wild animals become increasingly impor-
tant in the spread and maintenance of M. bovis infection,
especially when the efforts to eradicate the disease in live-
stock have reduced its incidence in domestic cattle [2,4].
The existence of wildlife tuberculosis (TB) reservoirs and
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the difficulty of controlling the disease in these species is
the most important complication in eradication programs
[3]. Well known examples of wildlife TB reservoirs include
the badger (Meles meles) in the United Kingdom and Ire-
land [5,6], the brushtail possum (Trichosurus vulpecula) in
New Zealand [3], the white-tailed deer (Odocoileus virgin-
ianus) in the north of the United States of America [7], the
buffalo (Syncerus caffer) in South Africa [8,9], or the bison
(Bison bison) in Canada [10].
In Spain, TB prevalence is relatively low in cattle (0.42 in
2006), but the infection persists in other livestock includ-
ing goats and free-ranging swine, and there is a wide range
of wild animal species susceptible to this disease [11]. Pre-
vious research suggested inter-specific transmission of the
M. tuberculosis complex among wild ungulates and live-
stock [11-14]. The European wild boar (Sus scrofa) is one
of the ungulates involved in the epidemiology of tubercu-
losis in Spain. Recent epidemiological, pathological and
microbiological evidence strongly suggests that, at least in
Spanish Mediterranean ecosystems, wild boar are able to
maintain TB infection in the wild and most likely can
transmit the disease to other species, acting as a true wild-
life reservoir [15]. Depending on risk factors such as host
age and management including feeding and fencing, wild
boar TB prevalence ranges based on gross pathology from
18 to 100% [16,17]. The diagnosis of M. bovis infection in
live animals generally depends on the cellular immune
response to M. bovis antigens in the first stages of the infec-
tion [18]. The most usual technique is the hypersensitivity
test, based on the intradermal injection of raw antigens
[19-21]. This skin testing technique, described by Robert
Koch, is still the most widely used tuberculosis diagnostic
method in livestock. It is also used in wild ruminants
[22,23]. However, skin tests have a limited sensitivity, and
non specific reactions may occur in animals sensitized by
mycobacteria other than those of the M. tuberculosis com-
plex [24,25].
In wild animals, any diagnostic test has an associated risk
during the capture, both for the people who handle the
animal and for the animal itself, due to handling stress
and injuries. Moreover, preliminary results of skin testing
in wild boar of known TB status suggest a low sensitivity
(unpublished data). Thus, the possibility of a test based
on a single sampling would be highly desirable for assess-
ing the prevalence, studying the mechanisms of transmis-
sion and monitoring the effects of control measures.
While the delayed-type hypersensitivity reaction is indica-
tive of infection or exposure, antibody formation appears
to be more closely related to the extent of bacterial multi-
plication and antigenic load in the infected individual.
ELISA testing is not routinely used in bovine TB control
programs mainly due to a reduced sensitivity [26],
although it has been suggested to be used as a comple-
ment to the tuberculin test, especially for the detection of
anergic tuberculous cattle [27,28].
The aim of this study was to develop and validate an
ELISA test for the detection of Mycobacterium bovis anti-
bodies in wild boar serum. To achieve this goal, the
humoral immune response measured by this test was first
measured in captive wild boar sensitized with inactivated
bacterial antigens and then results were validated with
sera obtained from wild boar of known microbiological
TB status.
Results
Humoral response to mycobacterial antigens
The two M. bovis immunized wild boars (WB1 and WB4)
developed a large increase in the level of antibodies
between pre-immunization (S1) and 30 days post-immu-
nization (S2) serum samples while showing a much
smaller increase at 90 days post-immunization (Table 1;
Figure 1). The other two wild boar, immunized with M.
avium  (WB3) and M. paratuberculosis (WB2), showed a
much smaller increase in the antibody level against
bovine PPD between the pre-immunization sampling and
controls S2 and S3 (Table 1).
The optical densities (OD) obtained showed better dis-
crimination at greater dilutions, but at serum dilutions
higher than 1/200 we observed a decrease in OD values
converging to blank readings. Sera reacted with both con-
jugates, Protein G and Protein A, but OD values were
more homogeneous and the discrimination was higher
with Protein G. Finally, serum dilution and conjugate Pro-
tein G concentration combinations showing the highest
increases between S1 and S2 were retained for validation
with the known status sera: 1/10–0.05 μg/ml, 1/200–2.5
μg/ml, 1/200–0.5 μg/ml and 1/200–0.05 μg/ml.
Known status sera analysis and determination of cut-off 
value
The summary of ELISA results in Table 2 shows that at the
highest semi-sum, specificities were > 93% and sensitivi-
ties > 69% in all combinations. The best semi-sum was
obtained at 1/200 serum dilution and 2.5 μg/ml conju-
gate concentration. These dilutions yielded the highest
sensitivity (80.26%) among all tested combinations, but
at the same time the specificity was reduced to 95.61%.
The next best combination was that of a 1/200 serum dilu-
tion and a conjugate concentration of 0.05 μg/ml, with
72.60% sensitivity and 96.43% specificity.
In order to assess the reproducibility of the ELISA and to
validate the test, the two latter combinations (1/200 and
2.5 μg/ml, and 1/200 and 0.05 μg/ml) were repeated in
two different days. It was observed that the replicates inBMC Veterinary Research 2008, 4:43 http://www.biomedcentral.com/1746-6148/4/43
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case of the combination 1/200 and 0.05 μg/ml varied less
than those of the other combination. Besides, the coeffi-
cient of variation (CV) between days of each test was
smaller and the dynamic range was broader too for the 1/
200 and 0.05 μg/ml combination (Table 3).
Figure 2 shows the dynamics of sensitivity, specificity,
diagnostic value semi-sum, SeDI and SpDI values for the
ELISA with 1/200 and 0.05 μg/ml sera/conjugate combi-
nation. It can be seen that the range between 0.115 and
0.655 has diagnostic values over 80%, with a slightly
higher primary peak between 0.195 and 0.275 and a sec-
ondary one between 0.415 and 0.475. The SeDI and SpDI
peak on both sides of the first peak, and indicate the opti-
mal performance when either sensitivity or specificity is
the main focus for the test. If a good balance is the goal,
then an intermediate value should be the choice. In this
case, and taking into account the distribution shown in
the histogram (Figure 3) a value at around 0.2 appears to
provide the best trade-off. This figure shows that there are
Increase rate (S2/S1) in the optical density reading of the ELISA with bovine PPD and protein G in WB1 and WB4 (immunized  with M. bovis), WB2 (M. avium paratuberculosis) and WB3 (M. avium) Figure 1
Increase rate (S2/S1) in the optical density reading of the ELISA with bovine PPD and protein G in WB1 and 
WB4 (immunized with M. bovis), WB2 (M. avium paratuberculosis) and WB3 (M. avium).
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Table 1: Average OD readings for serum dilution and protein G combination.
Serum dilution Protein G dilution
1/10 1/100 1/200 1/500 1/1000 1/2500 2.5 μg/ml 1 μg/ml 0.5 μg/ml 0.05 μg/ml
WB1 + WB4 S2/S1 9,2805 9,2610 9,6143 9,5895 9,1172 6,4596 6,3067 8,3368 10,702 11,129
S3/S1 10,465 11,061 11,38 11,574 11,730 9,1666 7,5116 10,252 12,074 13,751
S1 0,1758 0,1089 0,0855 0,0596 0,0465 0,0355 0,1428 0,0981 0,0728 0,0275
S2 1,0053 0,8198 0,7176 0,57 0,4293 0,2521 0,7832 0,729 0,6658 0,3514
S3 1,0706 0,9049 0,7892 0,6605 0,5357 0,3438 0,8763 0,8273 0,7576 0,4086
WB2 S2/S1 1,4873 1,2624 1,2840 1,1513 1,2033 1,1837 1,2756 1,2966 1,3386 1,1372
S3/S1 5,9384 5,5608 5,0313 3,6979 2,8577 2,3318 4,0252 4,7892 5,1064 3,0244
S1 0,0941 0,0669 0,055 0,0523 0,0414 0,0305 0,094 0,062 0,0491 0,0217
S2 0,1473 0,0841 0,0719 0,061 0,0504 0,0353 0,125 0,0844 0,0657 0,0248
S3 0,5771 0,3818 0,2885 0,2023 0,1224 0,0686 0,4152 0,3324 0,2779 0,0683
WB2 S2/S1 3,1229 2,4333 2,6135 2,0944 1,8366 1,4173 2,2195 2,3216 2,5731 1,8978
S3/S1 4,0662 3,3376 4,0625 3,1850 2,8014 2,1894 3,0310 3,3525 3,7237 2,9875
S1 0,1119 0,0671 0,054 0,0611 0,0485 0,0383 0,1052 0,0704 0,0543 0,0241
S2 0,3505 0,1645 0,145 0,1318 0,0914 0,0543 0,2504 0,8477 0,1515 0,0464
S3 0,41 0,2215 0,2269 0,1994 0,1374 0,0839 0,3213 0,8577 0,213 0,0731
All protein G concentrations at each serum dilution, and all serum dilutions at each protein G concentration.
WB1+WB4: Sum of wild boar 1 and wild boar 4 results. S2/S1 and S3/S1: Increase rate between pre- and post-immunization results. S1, S2 and S3: 
OD values.BMC Veterinary Research 2008, 4:43 http://www.biomedcentral.com/1746-6148/4/43
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at least bimodal distributions both for reference negative
and positive sera. This bimodal distribution is less clear
for the negative set since all but four sera locate below the
0.2 cut-off. The positives have a highly polarized distribu-
tion with markedly high modes at both ends of the EI
range and an almost continuous distribution between
them. Therefore a cut-off of 0.200 was finally chosen as
the one yielding the best balance between sensitivity and
specificity and locating to a region where no values were
found thus indicating a biological separation between EI
populations.
Discussion
To date, studies are not available on the experimental use
of antigens to characterize the immune response of wild
boar and pigs against M. bovis. Herein, inactivated myco-
bacterial antigens were successfully used to stimulate a
specific humoral immune response in healthy wild boar.
Injection of the antigens caused an increase of specific
antibodies, but the administration of a second antigen
dose did not raise the antibody levels so much. A strong
cross reaction between antibodies specific for M. avium
and M. avium paratuberculosis (WB 2 and WB 3) and the
bovine PPD ELISA was not observed except to some extent
for WB2 after the boosting. Thus, the immunization assay
provided negative and positive M. bovis control sera to use
in the development of the ELISA, as well as for reference
in the future.
It is generally recognized that humoral immunity is not
important for tuberculosis diagnosis [29], but it may
nonetheless be useful to detect animals with severe illness
since antibody concentration is related to lesion distribu-
tion and severity, as well as to the number of bacilli
[18,22,26,30-32]. Mycobacterial infections induce anti-
body production in ruminants, but the profile of immu-
noglobulin (Ig) expression in M. bovis infected animals is
poorly understood [33-36]. In previous studies, Ig heavy
and light chains were up-regulated in European wild boar
infected with M. bovis [37]. However, serum determina-
tions suggested elevated levels of IgG in uninfected wild
boar when compared to M. bovis infected animals [38].
The mechanism of Ig differential expression in M. bovis
infected wild boar is unknown but may reflect different
stages during mycobacterial infection. Furthermore, dif-
ferential gene expression analysis in response to mycobac-
terial infection in wild boar suggest that antibody
responses against M. bovis may be important in natural
infections of wildlife species and may be used for bTB sur-
veillance and treatment monitoring [35,39-41].
Previous studies using ELISA tests achieved 74% sensitiv-
ity and 90% specificity in cattle [26], and 79% to 98% spe-
cificity and 37% sensitivity in ELISA used in badgers [41-
43], although the latter was increased for badgers with
progressive tuberculosis [44]. In addition, a positive
ELISA result in badgers was correlated with an enhanced
likelihood of a future positive culture result [45]. Various
Table 2: Sensitivity, specificity, semi-sum, specificity discriminating index (SpDI) and sensitivity discriminating index (SeDI) values of 
different combinations of sera and PrG conjugate.
ELISA SENSITIVITY SPECIFICITY SEMI-SUM SpDI SeDI
1/10–0.05 ug/ml 70,67% 93,81% 0,8224 11,4076 3,1979
1/200–2.5 ug/ml 80,26% 95,61% 0,8794 18,3000 4,8444
1/200–0.5 ug/ml 69,33% 97,35% 0,8334 26,1156 3,1743
1/200–0.05 ug/ml 72,60% 96,43% 0,8452 20,3288 3,5196
Table 3: Descriptive statistics at two selected combinations.
COMBINATION 1/200–0.05 μg/ml COMBINATION 1/200–2.5 μg/ml
ELISA 1 ELISA 2 ELISA 1 ELISA 2
n 182 182 183 183
Average 0,3578 0,4152 0,5485 0,4862
SD 0,4633 0,5475 0,3855 0,3572
CV 129% 132% 70% 73%
OD max. 1,3902 1,6046 1,3907 1,1906
OD min. 0,0127 0,0213 0,0544 0,0604
Range 1,3775 1,5833 1,3363 1,1302
CV average 13,85% 19,91%
CV max. 46,74% 94,32%
SD: Standard deviation; CV: Coefficient of variation; OD max.: Maximum optical density value; OD min.: Minimum optical density value; CV 
average: Average of coefficient of variation for each serum two replicates; CV max.: Maximum coefficient of variation for each serum two 
replicates.BMC Veterinary Research 2008, 4:43 http://www.biomedcentral.com/1746-6148/4/43
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mycobacterial antigens have also been used for bovine
tuberculosis ELISA in other studies. This includes for
example ELISA based on MPB70 and MPB83 in cattle,
which have reported specificities of 89% and 96.4%, and
sensitivities of 18.1% and 37.5% [46,47]. The results
obtained in the current study, thus, indicate that the ELISA
performance was substantially better for wild boar, espe-
cially in terms of sensitivity (72.60%) and without a sig-
nificant loss in specificity (96.43%) despite the fact that it
is generally recognized that the sensitivities and specifici-
ties of ELISA protocols for serodiagnosis of bovine tuber-
culosis are low as compared to those for other diseases
[48].
At the chosen cut-off, there were a few reference negative
animals that had medium level antibody reactivity against
bovine PPD. It might be possible that some of these ani-
mals were infected individuals without visible lesions and
bacteria not found, or true non-infected but exposed to M.
bovis infection, that is, potentially resistant animals. Actu-
ally, ELISA positive results are usually considered only as
evidence of exposure [17] and not necessarily of current
infection. Infections with other mycobacteria causing
cross-reactivity cannot be completely ruled out although,
given the origin of the animals in infected areas and the EI
gap to the rest of negative controls, we think they are less
likely to be involved. On the other hand there were ani-
mals where M. bovis was isolated that had very low EI
readings. These animals might represent recently infected
individuals not having developed yet a humoral immune
response or anergic animals with limited immune
responses due to poor body condition.
Conclusion
We conclude that the use of the serological ELISA test
developed herein may contribute to the diagnosis of TB in
wild boar and probably also in pigs, with an acceptable
sensitivity and specificity and without the need to handle
the animals twice as in the skin test. This ELISA test could
be used in the control of TB in wild boar through "test &
cull" schemes and in large-scale surveys [49]. These results
support the use of the ELISA test to complement other
techniques based on cellular response to characterize
mycobacterial infection in wild boar.
Dynamics of sensitivity (Sen), specificity (Spe), diagnostic value semi-sum (SE+SP), specificity discriminating index (SpDI) and  sensibility discriminating index (SeDI) at selected conditions (serum sample dilution 1/200 and PrG conjugate 0.05 μg/ml) Figure 2
Dynamics of sensitivity (Sen), specificity (Spe), diagnostic value semi-sum (SE+SP), specificity discriminating 
index (SpDI) and sensibility discriminating index (SeDI) at selected conditions (serum sample dilution 1/200 
and PrG conjugate 0.05 μg/ml).
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Methods
Reference sera
Wild boar immunization
In order to obtain serum controls to be used in the ELISA,
four captive adult wild boars living in a M. bovis free area
were used. On day 0, wild boar 1 (WB1) and 4 (WB4)
were immunized by the subcutaneous route with 1 ml of
a suspension containing 103–106 colony-forming units
(CFU; 2.5 mg) of heat inactivated M. bovis. Wild boar 3
(WB3) was immunized with 1 ml (103–106 CFU) of heat
inactivated M. avium (M. bovis and M. avium were kindly
provided by CZ Veterinaria), and wild boar 2 (WB2) with
1 ml (2.5 mg) of heat inactivated commercial M. avium
paratuberculosis  vaccine (Gudair®  CZ Veterinaria, S.L.,
Spain). Prior to immunization a serum sample (S1) was
taken from each animal. Thirty days later a second serum
sample (S2) was taken and all the animals were re-immu-
nized in the same way. Ninety days later a third serum
sample (S3) was taken from the four animals. All sera
were stored frozen at -20°C until used for testing. All ani-
mal use was supervised by the Neiker Committee on Ani-
mal Experimentation in accordance with Spanish laws.
Wild Boar of known TB status
In order to validate the ELISA, 185 sera obtained from
known TB status cases (known status sera) were analyzed.
This material included 73 sera from naturally TB positive
wild boar, defined as individuals with both tuberculosis
compatible lesions [50] and M. tuberculosis complex isola-
tion and PCR confirmation (data not shown). The mate-
rial also included 112 sera from TB negative wild boar,
defined as animals with no visible TB-compatible lesions
and negative culture. These sera were analyzed with the
optimized ELISA protocol, using S3 of WB1 or WB4 as
positive control and S1 as negative control.
Histogram of the distribution of the ELISA index values at the defined conditions (1/200 and 0.05 μg/ml) and according to the  status of the animals: positive (POSITIVE) or negative (NEGATIVE) Figure 3
Histogram of the distribution of the ELISA index values at the defined conditions (1/200 and 0.05 μg/ml) and 
according to the status of the animals: positive (POSITIVE) or negative (NEGATIVE). The horizontal line repre-
sents the chosen cut-off value.
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Indirect ELISA optimization
Bovine tuberculin purified protein derivative (bovine
PPD) (CZ Veterinaria, S.L., Spain) was diluted to 5 μg/ml
in carbonate buffer (63 mM, pH 9.6). Plates (High bind-
ing ELISA microplate, Greiner bio-one, Germany) were
coated with 100 μl of diluted PPD and used in fresh, with-
out any storage. Serum samples and controls, were
adsorbed (1/1) with Mycobacterium phlei saline suspen-
sion (5 gr/l; Dr. O. Fuentes, INIA, Spain), to remove non-
specific anti-Mycobacterium spp. antibodies. After an over-
night incubation at 4°C, samples were diluted in PBS-
Tween (0.14 M NaCl; 3 mM KCl; 10 mM Phosphate
buffer; 0.05 Tween 20; pH 7.4) and 100 μl of each dilu-
tion were added in duplicate in contiguous wells of the
bovine PPD coated plate and incubated for 2 hours at
room temperature. After three washings with PBS-Tween,
100 μl of Protein A or G were added and incubated for two
hours at room temperature. Again after three washings,
100 μl of ABTS substrate (Sigma-Aldrich) were added to
each well and incubated for 20 minutes in the dark at
room temperature. Optical densities (OD) were read with
405 and 450 nm filters (MultiskanEX, Thermolabsys-
tems). Sample result was expressed as an ELISA index (EI)
that was calculated as the ratio of the mean sample OD to
the mean OD of the positive controls.
Optimal dilutions of sera were determined by the evalua-
tion of the reactivity of serial dilutions (1/10; 1/100; 1/
200; 1/500; 1/1000 and 1/2500) and in combination of
serial dilutions of Protein G or Protein A conjugated with
recombinant peroxidase from Streptococcus sp. (2.5 μg/ml;
1 μg/ml; 0.5 μg/ml; 0.05 μg/ml) (Sigma-Aldrich) with ref-
erence serum samples S1, S2 and S3 from the four immu-
nized wild boar analyzed in duplicate. The serum dilution
and Protein G concentration at which the ratio between
S2 and S1 ODs were higher and apparently more repre-
sentative were selected for testing the whole set of known
status sera. These sera were then tested only at 4 different
combinations (serum dilution-PrG concentration): 1/10–
0.05 μg/ml, 1/200–2.5 μg/ml, 1/200–0.5 μg/ml and 1/
200–0.05 μg/ml.
Indirect ELISA validation
ELISA indices of the whole set of known status sera were
entered in a spreadsheet (RA Juste, unpublished), that
allowed to calculate sensitivity and specificity for each cut-
off. This spreadsheet also calculates the semi-sum of sen-
sitivity and specificity (diagnostic value ranging from 0 to
100) and the ratios of specificity to sensitivity (specificity
discriminating index – SpDI) and of sensitivity to specifi-
city (sensitivity discriminating index – SeDI). The spread-
sheet also plots all the values in a single graph that allows
seeing at once the behaviour of all these relevant variables
along the dynamic range of the test. A verification of these
analyses was made using the SigmaPlot (Addlink, Barce-
lona, Spain) graphics package that was also used to plot
the positive and negative known status sera EI histogram
and to calculate the 95% sensitivity and specificity confi-
dence intervals at each cut-off.
The final cut-off for the test was chosen as that that yielded
the highest semi-sum, was located in a region where small
changes in its numerical value did not change substan-
tially the semi-sum (Figure 2), and in the histogram was
located in the widest gap without values (Figure 3).
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